WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 56'2101 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 42'2171 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 9'511  9'449  9'382  9'310  9'235  8'872  8'559  8'311 
Births 114  113  112  111  109  91  117  93 
Surviving infants 114  113  112  111  109  91  116  93 
Pop. less than 5 years 565  560  555  549  546  463  553  487 
Pop. less than 15 years 1'588  1'563  1'549  1'545  1'554  1'635  1'535  1'628 
Female 15-49 years 2'131  2'130  2'122  2'107  2'085  1'982  2'048  1'902 

Number of reported case

(Click for retrospective incidence data for Sweden)
Diphtheria
Japanese encephalitis
Measles 30  26  25  59  29  1'786 
Mumps 33  38  24  34  52  37 
Pertussis 289  177  266  281  459  2'705  10'697  5'221 
Polio*
Rubella 50 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sweden)
Vaccine year result method % card seen                                                
BCG          24  23  23  21  20  16  13 
DTP1         
DTP3          98  98  98  98  98  99  99 
HepB_BD         
HepB3          30  29  27  23  16 
Hib3          98  98  98  98  98  98 
JapEnc         
MCV          97  96  97  97  96  91  96  88 
MCV2          95  95  94  95  94  94 
PCV1         
PCV3          98  60 
Pol3          98  98  98  98  98  99  99  97 
Rota1         
Rota_last         
Rubella1          97  96  97  97  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sweden)
BCG 24  24  24  24  23  16  13 
DTP1 99  99  99  99  99  99  99  99 
DTP3 98  98  98  98  98  99  99  99 
HepB3
Hib3 98  98  98  98  98  98 
MCV 97  97  97  97  96  91  96  88 
PCV3 98  98  98  98  60 
Pol3 98  98  98  98  98  99  99  97 
Rota_last

Number of districts in the country 290  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 98
From 80 to 89% 2
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-6 months; Yes risk groups
DTaPHibHepIPV 3, 5, 12 months; Yes risk groups HB (except children to HBsAg+ mothers)
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 5-6 years; Yes
HPV 10-12 years (x3); Yes girls
HepB birth; 1, 3, 5, 12 months; Yes Children to HBsAg+ mothers
Influenza >= 65 years; No and risk groups
MMR 18 months; 6-8 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Pneumo_ps > 65 years; No + medical risk groups
Tdap 14-16 years; Yes Children born from 2002; From 2016

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  NA  NA  NA 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number     NA  NA       

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 290  290  290  290  290  290  290 
Nº districts with DTP3 coverage >=80% number 290  290  290  289  290  290  290 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 251  244  252  251  234     
% of districts with MCV1 coverage >=95% From 0 to 100% 87  84  87  87  81     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%       NA  NA  NA  NA 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.